The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, MD and TSLA
The Klein Law Firm
Sep. 04, 2018
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Mercury Systems, Inc. (NASDAQGS: MRCY) Class Period: October 24, 2017 to April 24, 2018 Lead Plaintiff Deadline: September 10, 2018
The lawsuit alleges that Mercury Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Mercury’s decision to in-source processing was adversely impacting Mercury’s operating margins and free cash-flow generation and conversion; (ii) Mercury’s model was becoming structurally more working capital intensive; (iii) as a result of the foregoing, Mercury’s public statements were materially false and misleading at all relevant times.
Get additional information about the MRCY lawsuit: http://www.kleinstocklaw.com/pslra-c/mercury-systems?wire=3
MEDNAX, Inc. (NYSE: MD) Class Period: February 4, 2016 to July 27, 2017 Lead Plaintiff Deadline: September 10, 2018
The complaint alleges that throughout the class period MEDNAX, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's business model was not sustainable; and (2) Mednax's growth was in fact based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections. On April 20, 2017, Mednax announced negative financial results for the first quarter of 2017. Then on July 28, 2017, during an earnings call, Mednax announced that the Company failed to complete any acquisitions of anesthesiologist practices during the second quarter and disclosed that any future acquisitions were unlikely. Following this news, shares of Mednax fell from a close of $56.49 on July 27, 2017, to a close of $47.73 per share the following day.
Get additional information about the MD lawsuit: http://www.kleinstocklaw.com/pslra-c/mednax-inc?wire=3
Tesla, Inc. (NASDAQ: TSLA) Class Period: Purchasers of shares between August 7, 2018 and August 17, 2018 and/or who had open short positions or put options for Tesla as of August 7, 2018 or August 8, 2018 Lead Plaintiff Deadline: October 9, 2018
The complaint alleges Tesla, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) that the Defendants had not secured funding for the Going-Private Transaction; (2) that Musk’s statements that the Going-Private Transaction only required shareholder approval were false since the Going-Private Transaction required approval by the Company’s Board of Directors and even the Board was unaware of the funding referred to by Musk; (3) that the status and likelihood of the Going-Private Transaction was misrepresented to the market because financing for it had not been secured and Board approval was required, and (4) as a result of the foregoing, Defendants’ statements about Tesla’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
Get additional information about the TSLA lawsuit: http://www.kleinstocklaw.com/pslra-1/tesla-inc-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.